期刊文献+

血浆BNP-CRP-血小板联合检测与慢性充血性心力衰竭患者的相关性研究 被引量:5

Combined detection of plasma BNP-CRP-platelet and chronic congestive heart failure
原文传递
导出
摘要 目的:通过联合检测血浆B钠尿肽(BNP)、C反应蛋白(CRP)和血小板(PLT)水平与心功能的分级(NYHA)之间的关系,进行三者与充血性心力衰竭(CHF)患者的相关性研究。方法:选取CHF患者86例为一组,分别动态监测其血浆BNP、CRP及PLT水平,并选52名健康志愿者为对照组。结果:慢性充血性心衰患者血浆BNP、CRP与对照组比较差别有统计学意义(P<0.01),慢性充血性心衰患者的血小板(PLT)计数与对照组比较差别无统计学意义(P>0.05),慢性充血性心衰患者血小板体积分布宽度(PDW)与对照组比较差别有统计学意义(P<0.05),慢性心衰患者平均血小板体积(MPV)与对照组比较差别有统计学意义(P<0.01)。BNP、CRP与CHF严重程度有关(P<0.01,P<0.05)。结论:血浆BNP、CRP、PDW、MPV在CHF患者中明显升高,且升高幅度与病情的严重性相一致,对疗效观察和病情转归的判断有一定的临床价值。 Objective:To investigate the relation of the plasma levels of BNP,CRP and platelet to NYHA to explore the correlation of the 3 indexes with congestive heart failure(CHF).Methods:The plasma levels of BNP,CRP and platelet were dynamically monitored in 86 patients with CHF and 52 healthy individuals.Results:There were significant differences in plasma levels of BNP and CRP between the patients and controls(P0.01).However,there was no marked difference in plasma level of platelet between the 2 groups(P0.05).There were remarkable differences in PDW and MPV between the 2 groups(P0.05,0.01).The plasma levels of BNP and CRP were associated with severity of CHF(P0.01,0.05).Conclusion:The detection of plasma BNP,CRP,PDW and MPV can be used to monitor the disease course of CHF.
出处 《中国卫生检验杂志》 CAS 2010年第4期826-827,932,共3页 Chinese Journal of Health Laboratory Technology
关键词 心力衰竭 B钠尿肽 C反应蛋白 血小板 Heart failure BNP CRP Platelet
  • 相关文献

参考文献4

  • 1Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine - origin HINI influenza virus [ J ] . Nature, 2009, 459 ( 7249 ) : 931 - 939.
  • 2CDC protocol of realtime RTPCR for influenza A ( H1N1 ). http:// www. who. int/csr/resources/publications/swineflu/reahimeptpcr/en/ index. html.
  • 3卫生部办公厅.甲型H1N1流感监测方案.第1版.2009-5-12.
  • 4卫生部办公厅.甲型H1N1流感监测方案.第2版.2009-9-30.

共引文献1

同被引文献43

  • 1常锦峰,折芝莲,李旺林.依那普利治疗急性心肌梗死后心力衰竭30例疗效观察[J].现代医药卫生,2007,23(7):990-990. 被引量:1
  • 2陈世德,陶新智.慢性心力衰竭患者血浆血小板功能及纤溶活性的变化[J].临床心血管病杂志,2007,23(8):622-623. 被引量:6
  • 3Donal E, Lund L, Linde C, et al.Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project [J]. Arch Cardiovase Dis, 2010, 103 (6-7): 404-410.
  • 4Traverse JH, Henry TD, Vaughan DE, et al. LateTIME: a phase-Ⅱ, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction [J]. Tex Heart Inst J, 2010, 37 (4) : 412-420.
  • 5Abdcl Wahab M, Saad M, Kynast J, et al. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction [J]. Am J of Cardiol, 2010, 105(7): 967-971.
  • 6Kowalczyk E, Kasprzak JD,Lipiec P. Heart failure is an inde-pendent predictor of thrombus persistence in non - valvular atrialiibriliation - transesophageal echocardiography - based study[J].Pol Arch Med Wewn,2015,125(5) :358 - 362.
  • 7Hou M, Yu J,Zhang L, ef al .Changes and significance of P - se-lectin and PAC - 1 in coronary heart disease before and afterstenting[J] .Chin Medi J,2014,94( 10) : 766 - 768.
  • 8Januzzi JL, Camargo CA.The N - terminal Pro - BNP investiga-tion of dyspnea in the emergency department (PRIDE)study[J].Am J Cardiol,2005,95(8) :948- 954.
  • 9Parker AB, Yusuf S,Naylor CD. The relevance of subgroup -specific treatment effects: The Studies of Left Ventricular Dys-function CSOLVD) revisited[J].Am Heart J,2002,144(6) :941 -947.
  • 10Cleland JG,Findlay l,Jafri S,et al .The Warfarin/Aspirin Study inHeart Failure (WASH) : A randomized trial comparing antithrom-botic strategies for patients with heart failure [J]. Am Heart J,2004,148(1) :157- 164.

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部